Oncogenesis and transforming viruses: The hepatitis B virus and hepatocellularcarcinoma - The etiopathogenic link

Frontiers in Bioscience

Volumn 12, Issue 1, 2007, Pages 234-245

  Lee, Alvin T C ^a   Lee, Caroline G L ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

HBx; Hepatitis B virus; Hepatocellularcarcinogenesis; Hepatocellularcarcinoma; Review; Transforming viruses

Indexed keywords

HEPATITIS B VIRUS;

EID: 34249790278     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2061     Document Type: Article

References (109)

1. Hepatitis B. World Health Organization, Fact Sheet No.204 (2000).
2. Parkin, D. M., P. Pisani & J. Ferlay: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-841 (1999)
3. Seeger, C. & W. S. Mason: Hepatitis B virus biology. Microbiol Mol Biol Rev, 64, 51-68 (2000)
4. Feitelson, M. A.: Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol, 181, 188-202 (1999)
5. Arbuthnot, P. & M. Kew: Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol, 82, 77-100 (2001)
6. Zoulim, F.: New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol, 42, 302-308 (2005)
7. Brass, V. & W. H. Gerlich: Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology, 163, 268-275 (1988)
8. Ou, J. H., O. Laub & W. J. Rutter: Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A, 83, 1578-1582 (1986)
9. Jean-Jean, O., M. Levrero, H. Will, M. Perricaudet & J. M. Rossignol: Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology, 170, 99-106 (1989)
10. Wieland, S. F. & F. V. Chisari: Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol, 79, 9369-9380 (2005)
11. Wieland, S., R. Thimme, R. H. Purcell & F. V. Chisari: Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA, 101, 6669-6674 (2004)
12. Hoofhagle, J. H., G. M. Dusheiko, L. B. Seeff, E. A. Jones, J. G. Waggoner & Z. B. Bales: Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med, 94, 744-748 (1981)
13. Sells, M. A., M. L. Chen & G. Acs: Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A, 84, 1005-1009 (1987)
14. Sureau, C., J. L. Romet-Lemonne, J. I. Mullins & M. Essex: Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell, 47, 37-47 (1986)
15. Buendia, M. A.: Mammalian hepatitis B viruses and primary liver cancer. Semin Cancer Biol, 3, 309-320 (1992)
16. Minami, M., Y. Daimon, K. Mori, H. Takashima, T. Nakajima, Y. Itoh & T. Okanoue: Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene, 24, 4340-4348 (2005)
17. Wang, J., X. Chenivesse, B. Henglein & C. Brechot: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature, 343, 555-557 (1990)
18. Wang, J., F. Zindy, X. Chenivesse, E. Lamas, B. Henglein & C. Brechot: Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene, 7, 1653-1656 (1992)
19. Berasain, C., D. Patil, E. Perara, S. M. Huang, H. Mouly & C. Brechot: Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion. Oncogene, 16, 1277-1288 (1998)
20. Dejean, A. & H. de The: Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. Mol Biol Med, 7, 213-222 (1990)
21. Dejean, A., L. Bougueleret, K. H. Grzeschik & P. Tiollais: Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature, 322, 70-2 (1986)
22. Garcia, M., H. de The, P. Tiollais, J. Samarut & A. Dejean: A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro. Proc Natl Acad Sci U S A, 90, 89-93 (1993)
23. Zhou, Y. Z., B. L. Slagle, L. A. Donehower, P. vanTuinen, D. H. Ledbetter & J. S. Butel: Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol, 62, 4224-31 (1988)
24. Slagle, B. L., Y. Z. Zhou & J. S. Butel: Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res, 51, 49-54 (1991)
25. Gozuacik, D., Y. Murakami, K. Saigo, M. Chami, C. Mugnier, D. Lagorce, T. Okanoue, T. Urashima, C. Brechot & P. Paterlini-Brechot: Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene, 20, 6233-40 (2001)
26. Paterlini-Brechot, P., K. Saigo, Y. Murakami, M. Chami, D. Gozuacik, C. Mugnier, D. Lagorce & C. Brechot: Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene, 22, 3911-6 (2003)
27. Ferber, M. J., D. P. Montoya, C. Yu, I. Aderca, A. McGee, E. C. Thorland, D. M. Nagorney, B. S. Gostout, L. J. Burgart, L. Boix, J. Bruix, B. J. McMahon, T. H. Cheung, T. K. Chung, Y. F. Wong, D. I. Smith & L. R. Roberts: Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene, 22, 3813-20 (2003)
28. Horikawa, I. & J. C. Barrett: cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst, 93, 1171-3 (2001)
29. Murakami, Y., M. Minami, Y. Daimon & T. Okanoue: Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol, 12, 203-14 (2004)
30. Matsubara, K. & T. Tokino: Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med, 1, 243-60 (1990)
31. Robinson, W. S., L. Klote & N. Aoki: Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol, 31, 18-32 (1990)
32. Kekule, A. S., U. Lauer, M. Meyer, W. H. Caselmann, P. H. Hofschneider & R. Koshy: The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature, 343, 457-61 (1990)
33. Hildt, E., G. Saher, V. Bruss & P. H. Hofschneider: The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology, 225, 235-9 (1996)
34. Hildt, E. & P. H. Hofschneider: The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res, 154, 315-29 (1998)
35. Schluter, V., M. Meyer, P. H. Hofschneider, R. Koshy & W. H. Caselmann: Integrated hepatitis B virus X and 3 truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene, 9, 3335-44 (1994)
36. Zhong, S., J. Y. Chan, W. Yeo, J. S. Tarn & P. J. Johnson: Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. J Viral Hepat, 6, 195-202 (1999)
37. Hildt, E., S. Urban, U. Lauer, P. H. Hofschneider & A. S. Kekule: ER-localization and functional expression of the HBV transactivator MHBst. Oncogene, 8, 3359-67 (1993)
38. Hildt, E., S. Urban & P. H. Hofschneider: Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene, 11, 2055-66 (1995)
39. Hildt, E., B. Munz, G. Saher, K. Reifenberg & P. H. Hofschneider: The PreS2 activator MHBs (t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. Embo J, 21, 525-35 (2002)
40. Singh, M. & V. Kumar: Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma. Rev Med Virol, 13, 243-53 (2003)
41. Paterlini, P., K. Poussin, M. Kew, D. Franco & C. Brechot: Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology, 21, 313-21 (1995)
42. Vitvitski-Trepo, L., A. Kay, C. Pichoud, P. Chevallier, S. de Dinechin, B. M. Shamoon, E. Mandart, C. Trepo & F. Galibert: Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology, 12, 1278-83 (1990)
43. Mandart, E., A. Kay & F. Galibert: Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol, 49, 782-92 (1984)
44. Sprengel, R., E. F. Kaleta & H. Will: Isolation and characterization of a hepatitis B virus endemic in herons. J Virol, 62, 3832-9 (1988)
45. Kim, C. M., K. Koike, I. Saito, T. Miyamura & G. Jay: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-20 (1991)
46. Koike, K., K. Moriya, H. Yotsuyanagi, S. lino & K. Kurokawa: Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest, 94, 44-9 (1994)
47. Terradillos, O., O. Billet, C. A. Renard, R. Levy, T. Molina, P. Briand & M. A. Buendia: The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene, 14, 395-404 (1997)
48. Slagle, B. L., T. H. Lee, D. Medina, M. J. Finegold & J. S. Butel: Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog, 15, 261-9 (1996)
49. Koike, K., K. Moriya, S. lino, H. Yotsuyanagi, Y. Endo, T. Miyamura & K. Kurokawa: High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology, 19, 810-9 (1994)
50. Lee, A. T., J. Ren, E. T. Wong, K. H. Ban, L. A. Lee & C. G. Lee: The Hepatitis B Virus X Protein Sensitizes HepG2 Cells to UV Light-induced DNA Damage. J Biol Chem, 280, 33525-35 (2005)
51. Maguire, H. F., J. P. Hoeffler & A. Siddiqui: HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science, 252, 842-4 (1991)
52. Qadri, I., H. F. Maguire & A. Siddiqui: Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA, 92, 1003-7 (1995)
53. Barnabas, S., T. Hai & O. M. Andrisani: The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem, 272, 20684-90 (1997)
54. Cheong, J. H., M. Yi, Y. Lin & S. Murakami: Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. Embo J, 14, 143-50 (1995)
55. Lin, Y., T. Nomura, J. Cheong, D. Dorjsuren, K. Iida & S. Murakami: Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem, 272, 7132-9 (1997)
56. Qadri, I., J. W. Conaway, R. C. Conaway, J. Schaack & A. Siddiqui: Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci U S A, 93, 10578-83 (1996)
57. Feitelson, M. A., M. Zhu, L. X. Duan & W. T. London: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8, 1109-17 (1993)
58. Takada, S., N. Tsuchida, M. Kobayashi & K. Koike: Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis. J Cancer Res Clin Oncol, 121, 593-601 (1995)
59. Wang, X. W., K. Forrester, H. Yeh, M. A. Feitelson, J. R. Gu & C. C. Harris: Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA, 91, 2230-4 (1994)
60. Lucito, R. & R. J. Schneider: Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol, 66, 983-91 (1992)
61. Su, F. & R. J. Schneider: Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol, 70, 4558-66 (1996)
62. Natoli, G., M. L. Avantaggiati, P. Chirillo, P. L. Puri, A. lanni, C. Balsano & M. Levrero: Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene, 9, 2837-43 (1994)
63. Benn, J. & R. J. Schneider: Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA, 91, 10350-4 (1994)
64. Benn, J., F. Su, M. Doria & R. J. Schneider: Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol, 70, 4978-85 (1996)
65. Klein, N. P. & R. J. Schneider: Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol, 17, 6427-36 (1997)
66. Nomura, T., Y. Lin, D. Dorjsuren, S. Ohno, T. Yamashita & S. Murakami: Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation. Biochim Biophys Acta, 1453, 330-40 (1999)
67. Hoare, J., F. Henkler, J. J. Dowling, W. Errington, R. D. Goldin, D. Fish & M. J. McGarvey: Subcellular localisation of the X protein in HBV infected hepatocytes. J Med Virol, 64, 419-26 (2001)
68. Doria, M., N. Klein, R. Lucito & R. J. Schneider: The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. Embo J, 14, 4747-57 (1995)
69. Chisari, F. V. & C. Ferrari: Hepatitis B virus immunopathology. Springer Semin Immunopathol, 17, 261-81 (1995)
70. Teodoro, J. G. & P. E. Branton: Regulation of apoptosis by viral gene products. J Virol, 71, 1739-46 (1997)
71. Chirillo, P., S. Pagano, G. Natoli, P. L. Puri, V. L. Burgio, C. Balsano & M. Levrero: The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA, 94, 8162-7 (1997)
72. Sirma, H., C. Giannini, K. Poussin, P. Paterlini, D. Kremsdorf & C. Brechot: Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene, 18, 4848-59 (1999)
73. Terradillos, O., T. Pollicino, H. Lecoeur, M. Tripodi, M. L. Gougeon, P. Tiollais & M. A. Buendia: p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene, 17, 2115-23 (1998)
74. Koike, K., K. Moriya, H. Yotsuyanagi, Y. Shintani, H. Fujie, T. Tsutsumi & S. Kimura: Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Cancer Lett, 134, 181-6 (1998)
75. Lau, J. Y., X. Xie, M. M. Lai & P. C. Wu: Apoptosis and viral hepatitis. Semin Liver Dis, 18, 169-76 (1998)
76. Bergametti, F., D. Sitterlin & C. Transy: Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J Virol, 76, 6495-501 (2002)
77. Abramic, M., A. S. Levine & M. Protic: Purification of an ultraviolet-inducible, damage-specific DNA-binding protein from primate cells. J Biol Chem, 266, 22493-500 (1991)
78. Nag, A., A. Datta, K. Yoo, D. Bhattacharyya, A. Chakrabortty, X. Wang, B. L. Slagle, R. H. Costa & P. Raychaudhuri: DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1. J Virol, 75, 10383-92 (2001)
79. Bontron, S., N. Lin-Marq & M. Strubin: Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J Biol Chem, 277, 38847-54 (2002)
80. Zhang, X., N. Dong, L. Yin, N. Cai, H. Ma, J. You, H. Zhang, H. Wang, R. He & L. Ye: Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol, 77, 374-81 (2005)
81. Marusawa, H., S. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm & J. C. Reed: HBXIP functions as a cofactor of survivin in apoptosis suppression. Embo J, 22, 2729-40 (2003)
82. Melegari, M., P. P. Scaglioni & J. R. Wands: Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol, 72, 1737-43 (1998)
83. Schwartz, D. & V. Rotter: p53-dependent cell cycle control: response to genotoxic stress. Semin Cancer Biol, 8, 325-36 (1998)
84. Lane, D. P.: Cancer. p53, guardian of the genome Nature, 358, 15-6 (1992)
85. Staib, F., S. P. Hussain, L. J. Hofseth, X. W. Wang & C. C. Harris: TP53 and liver carcinogenesis. Hum Mutai, 21, 201-16 (2003)
86. Elmore, L. W., A. R. Hancock, S. F. Chang, X. W. Wang, S. Chang, C. P. Callahan, D. A. Geller, H. Will & C. C. Harris: Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA, 94, 14707-12 (1997)
87. Takada, S., N. Kaneniwa, N. Tsuchida & K. Koike: Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene, 15, 1895-901 (1997)
88. Ueda, H., S. J. Ullrich, J. D. Gangemi, C. A. Kappel, L. Ngo, M. A. Feitelson & G. Jay: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet, 9, 41-7 (1995)
89. Arbuthnot, P., A. Capovilla & M. Kew: Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol, 15, 357-68 (2000)
90. Becker, S. A., T. H. Lee, J. S. Butel & B. L. Slagle: Hepatitis B virus X protein interferes with cellular DNA repair. J Virol, 72, 266-72 (1998)
91. Groisman, I. J., R. Koshy, F. Henkler, J. D. Groopman & M. A. Alaoui-Jamali: Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinogenesis, 20, 479-83 (1999)
92. Madden, C. R., M. J. Finegold & B. L. Slagle: Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol, 74, 5266-72 (2000)
93. Chresta, C. M., E. L. Arriola & J. A. Hickman: Apoptosis and cancer chemotherapy. Behring Inst Mitt232-40 (1996)
94. Prost, S., J. M. Ford, C. Taylor, J. Doig & D. J. Harrison: Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J Biol Chem, 273, 33327-32 (1998)
95. Wang, X. W., M. K. Gibson, W. Vermeulen, H. Yeh, K. Forrester, H. W. Sturzbecher, J. H. Hoeijmakers & C. C. Harris: Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res, 55, 6012-6 (1995)
96. Wang, X. W., H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J. M. Egly, Z. Wang, E. C. Freidberg, M. K. Evans, B. G. Taffe & et al.: p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet, 10, 188-95 (1995)
97. Jia, L., X. W. Wang & C. C. Harris: Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer, 80, 875-9 (1999)
98. de Vries, A., C. T. van Oostrom, F. M. Hofhuis, P. M. Dortant, R. J. Berg, F. R. de Gruijl, P. W. Wester, C. F. van Kreijl, P. J. Capel, H. van Steeg & et al.: Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature, 377, 169-73 (1995)
99. Sands, A. T., A. Abuin, A. Sanchez, C. J. Conti & A. Bradley: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature, 377, 162-5 (1995)
100. Bellamy, C. O., A. R. Clarke, A. H. Wyllie & D. J. Harrison: p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. Faseb J, 11, 591-9 (1997)
101. Fischer, M., L. Runkel & H. Schaller: HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alphasubunit. Virus Genes, 10, 99-102 (1995)
102. Sirma, H., R. Weil, O. Rosmorduc, S. Urban, A. Israel, D. Kremsdorf & C. Brechot: Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene, 16, 2051-63 (1998)
103. Hu, Z., Z. Zhang, E. Doo, O. Coux, A. L. Goldberg & T. J. Liang: Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol, 73, 7231-40 (1999)
104. Chen, X., Y. Zhang, L. Douglas & P. Zhou: UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation. J Biol Chem, 276, 48175-82 (2001)
105. Hwang, B. J., S. Toering, U. Francke & G. Chu: p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity. Mol Cell Biol, 18, 4391-9 (1998)
106. Tang, J. Y., B. J. Hwang, J. M. Ford, P. C. Hanawalt & G. Chu: Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol Cell, 5, 737-44 (2000)
107. Lee, T. H., S. J. Elledge & J. S. Butel: Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol, 69, 1107-14 (1995)
108. Kamiya, N.: The mechanisms of action of antivirals against hepatitis B virus infection. J Antimicrob Chemother, 51, 1085-9 (2003)
109. Wong, E. T., Y. P. Chew, L. A. Lee & C. G. Lee: Therapeutic strategies for hepatitis B virus-associated hepatocellular carcinoma. Curr Drug Targets, 3, 369-78 (2002)